# SpecGx LLC - Inspection Records

Source: https://www.keypedia.com/companies/specgx-llc/a659fe71-9183-4c7c-96ca-9214c6a9c177

> Inspection records and compliance data for SpecGx LLC in Saint Louis, Missouri. Access full analysis and detailed observations.

---

## Details

- Name: SpecGx LLC
- FEI Number: 1940521
- City: Saint Louis
- State: Missouri
- Country Name: United States
- Address Line 1: 3600 N 2nd St
- Zip Code: 63147
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - SpecGx LLC - 2025-10-22](https://www.keypedia.com/records/483/specgx-llc/4c5da907-2510-41e1-8137-0501072d41a1) — source: FDA, date: October 22, 2025
- [FDA Inspection 1283454 - SpecGx LLC - 2025-10-22](https://www.keypedia.com/records/fda_inspections/specgx-llc/24ece6fd-a035-4331-89ab-8ddb59db42f9) — source: FDA, date: October 22, 2025
- [FDA Inspection 1283454 - SpecGx LLC - 2025-10-22](https://www.keypedia.com/records/fda_inspections/specgx-llc/4ef58d63-e23f-4c06-9834-380b593fbb90) — source: FDA, date: October 22, 2025
- [FDA Inspection 1283454 - SpecGx LLC - 2025-10-22](https://www.keypedia.com/records/fda_inspections/specgx-llc/4554a61d-9334-4f7c-8b16-11f2c2cbfe6a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 22, 2025
- [FDA Inspection 1283454 - SpecGx LLC - 2025-10-22](https://www.keypedia.com/records/fda_inspections/specgx-llc/cbc1b2fb-753f-4dd6-aa20-30ef2fbc7c06) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 22, 2025
- [FDA Inspection 1163660 - SpecGx LLC - 2022-02-11](https://www.keypedia.com/records/fda_inspections/specgx-llc/42e52827-265a-4039-8bff-a00d227c7ee8) — classification: No Action Indicated (NAI), source: FDA, date: February 11, 2022
- [FDA Inspection 1103208 - SpecGx LLC - 2019-09-12](https://www.keypedia.com/records/fda_inspections/specgx-llc/75d21b61-9c72-4784-bf5f-16c5e92499a8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 12, 2019
- [483 - SpecGx LLC - 2019-09-09](https://www.keypedia.com/records/483/specgx-llc/67fec33d-bdc1-4d7f-8e23-3a7fe20180cd) — source: FDA, date: September 9, 2019
- [EIR - SpecGx LLC - 2016-11-22](https://www.keypedia.com/records/eir/specgx-llc/da450be6-28a1-4082-b2f0-8f3b74f29ee5) — source: FDA, date: November 22, 2016
- [FDA Inspection 994662 - SpecGx LLC - 2016-11-22](https://www.keypedia.com/records/fda_inspections/specgx-llc/6828282d-6ad1-439a-b2b4-d13d284884a0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2016
- [FDA Inspection 883175 - SpecGx LLC - 2014-06-12](https://www.keypedia.com/records/fda_inspections/specgx-llc/4735a37b-90ed-4290-88c9-a2ec11c40e7d) — classification: No Action Indicated (NAI), source: FDA, date: June 12, 2014
- [FDA Inspection 834018 - SpecGx LLC - 2013-05-24](https://www.keypedia.com/records/fda_inspections/specgx-llc/3cfd1ffd-8673-4de0-a3ad-1f2293474b09) — classification: No Action Indicated (NAI), source: FDA, date: May 24, 2013
- [FDA Inspection 665303 - SpecGx LLC - 2010-06-04](https://www.keypedia.com/records/fda_inspections/specgx-llc/e742867d-454e-4acf-8610-9856154c9d37) — classification: No Action Indicated (NAI), source: FDA, date: June 4, 2010

## Related Companies

- [Allergan Sales, LLC](https://www.keypedia.com/companies/allergan-sales-llc/1c953156-6298-4351-8d2d-bc0fa979d4eb)
- [AbbVie Bioresearch Center](https://www.keypedia.com/companies/abbvie-bioresearch-center/6957449c-4de8-444b-b53c-5838b33a76a1)
- [Nova-Tech Inc.](https://www.keypedia.com/companies/nova-tech-inc/fe5c85d8-9a42-4481-bdf4-1df3773fe907)
- [Eriochem SA](https://www.keypedia.com/companies/eriochem-sa/e2f01909-c1a5-49e0-a736-041a0c65beba)
- [Baxalta Manufacturing Sarl](https://www.keypedia.com/companies/baxalta-manufacturing-sarl/71d79fb0-4c45-4139-b2d0-a6e38551344e)
- [Baxalta US Incorporated](https://www.keypedia.com/companies/baxalta-us-incorporated/bb2b5b07-7c9c-4fce-b969-4dc5fa402b64)
- [Janssen Biotech, Inc.](https://www.keypedia.com/companies/janssen-biotech-inc/5374365d-a0df-4a87-ad3d-2714628d3e57)
- [Genzyme Flanders](https://www.keypedia.com/companies/genzyme-flanders/5f71d574-8097-4cd8-9254-2f8b85700e59)
- [Syngene International Ltd.](https://www.keypedia.com/companies/syngene-international-ltd/11ddfe19-cf6b-48b5-b7ab-8e3236ac3636)
- [Alk-abello A/s](https://www.keypedia.com/companies/alk-abello-as/40a1685c-dc02-464f-a52b-4678d31929ed)

## Related Officers

- [company_representative](https://www.keypedia.com/people/steve-e-nelms/1676a453-ebb7-4c48-9cbe-b1408fc95117)
- [company_representative](https://www.keypedia.com/people/rachel-l-fuller/170d2f45-10db-4c4b-8447-6339b57735a5)
- [Wayne D. Mcgrath](https://www.keypedia.com/people/wayne-d-mcgrath/42db5ab0-2e0b-4909-951c-e7621cd04f6e)
- [Investigator](https://www.keypedia.com/people/sarah-e-rhoades/d965990c-15cc-4722-b2d0-aea7206c71b0)
- [Aerial A. Smith](https://www.keypedia.com/people/aerial-a-smith/1f2a9d0e-91b0-4e59-ace1-0527785217e1)
- [Investigator?](https://www.keypedia.com/people/robert-j-ham/9146e819-4fce-420c-a722-cbe14e3c6afb)